Nulojix savings card: as little as $50 an infusion with commercial insurance

Nulojix is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How to pay the least

Given by your care team

Billed by the clinic

Nulojix is given by a doctor or nurse, not picked up at a pharmacy.

Ask your care team or your plan what you’d pay before your visit.

Compare every option

Brand nameNulojix

Authorized genericbelatacept

Regular genericbelatacept

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldAsk the pharmacy

Same as Nulojix?

The original

–

Brand nameThe maker’s card

BMS Access Support Co-Pay Assistance Program for NULOJIX (Kidney Transplant Co-Pay Assistance Program)

Savings card from Bristol Myers Squibb

No insuranceNeeds insuranceNo cash price listed.

Insurance · as little as $50 an infusion

The card takes up to $7,000 a year off your co-pay.

Or call 1-800-861-0048.

In the maker’s words

“Enrolled patients may pay as little as $50 per infusion…”

From the maker’s offer on bmsaccesssupport.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Nulojix itself, from the same company, sold without the brand name, and usually for less. For now Nulojix is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Nulojix is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

Preventing rejection of a kidney transplant

What the FDA label says

NULOJIX is a selective T cell costimulation blocker indicated for prophylaxis of organ rejection in adult patients receiving a kidney transplant.
Use in combination with basiliximab induction, mycophenolate mofetil, and corticosteroids.

Limitations of Use:

Use only in patients who are EBV seropositive.
Use has not been established for the prophylaxis of organ rejection in transplanted organs other than the kidney.

Source: the FDA label for Nulojix (E.R. Squibb & Sons, L.L.C.), July 28, 2021. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to the clinic’s billing office.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/nulojix/